2018 Blood Typing, Grouping and NAT Screening Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers

January 2018 | 114 pages | ID: 22613930552EN
Venture Planning Group

Abstracts

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking.

The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 114 pages

Contents

Current and Emerging Technologies
Molecular Diagnostics
    a. Overview
    b. NAT
Monoclonal and Polyclonal Antibodies
Immunoassays
    a. Technological Principle
    b. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
Microtitration Plates
IT and Automation
Lasers
Robotics
Synthetic Red Cell Substitutes
Genetically Engineered Blood Components
    a. Albumin
    b. Factor VIII
    c. Alpha2 Antiplasmin
    d. Antithrombin III
    e. Factor IX
    f. Von Willebrand's Factor
    g. Fibrinogen
    h. tPA
Blood Preservation
Autologous Blood Transfusion/Freezing

COMPETITIVE PROFILES

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
BioRad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/GenProbe
Immucor
OrthoClinical Diagnostics
Proteome Sciences
Roche
Siemens
Tecan
Thermo Fisher